Article Text

PDF
Increased ergothioneine tissue concentrations in carriers of the Crohn’s disease risk-associated 503F variant of the organic cation transporter OCTN1
  1. D Taubert1,
  2. N Jung2,
  3. T Goeser3,
  4. E Schömig1
  1. 1
    Department of Pharmacology, University Hospital of Cologne, Cologne, Germany
  2. 2
    Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
  3. 3
    Department of Gastroenterology and Hepatology, University Hospital of Cologne, Cologne, Germany
  1. Dr D Taubert, Department of Pharmacology, University Hospital of Cologne, Gleueler Str. 24, D-50931 Cologne, Germany; dirk.taubert{at}medizin.uni-koeln.de

Statistics from Altmetric.com

Accumulating evidence suggests that genetic susceptibility to Crohn’s disease (CD) is driven by loss-of-function mutations in established risk genes such as IBD5, NOD2/CARD15, ATG16L1 or IL23R conferring defects in the innate immune response.1 2

Within the IBD5 locus, a coding variant of the organic cation transporter OCTN1 (SLC22A4) has been associated with the risk of CD in Caucasian populations.3 4 However, the causal involvement of OCTN1 in CD pathogenesis is unclear, because the OCTN1 variant is in linkage disequilibrium with other IBD5 alleles, in particular with a promoter variant of the carnitine transporter OCTN2 (SLC22A5).3

We have previously demonstrated that the food ingredient ergothioneine (ET), not arising from mammalian metabolism or intestinal flora, represents the key substrate of OCTN15 and that the CD risk-associated variant 503F (1672T) exhibits a …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.